Skip to main content
Toggle navigation
Login
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Ticket Required
Food
Coffee
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
0
01. Adverse Drug Reaction Rates and Management with Ustekinumab in Inflammatory Bowel Disease
Favorite
02. Ocrelizumab in Multiple Sclerosis: Comparing Treatment-Naïve versus Non-Naïve Patients in Home Infusion
Favorite
03. The Operational Impact of Parenteral Nutrition Drug Shortages
Favorite
04. Utilization and Tolerability of Anifrolumab-fnia in Home Infusion Patients
Favorite
05. Utilization and Tolerability of Crizanlizumab in the Home and Alternate Infusion Settings
Favorite
06. Utilization of Alternative Dosing Strategies for Infliximab and Infliximab Biosimilars in the Home Infusion Setting
Favorite
07. Utilization, Tolerability, and Operational Impact of Intravenous Iron in Home Infusion Patients
Favorite
08. Home Parenteral Nutrition Diagnosis and Payer Trends: 2020-2023
Favorite
09. Impact of the Home Nutrition Support Team on Fistula Output and PN Tolerance: A Case Study
Favorite
1
10. A Real-World Evaluation of the Impact of One Intravenous Immunoglobulin Product on Patients with Chronic Inflammatory Demyelinating Polyneuropathy – Tolerability, Reported Outcomes, Satisfaction
Favorite
11. The Use of Immune Globulin Intravenous, Human-slra 10% Therapy in Lung Transplant Recipients
Favorite
12. Social Determinants of Health Impact on Participant Perception with Home Infusion of Intravenous Immunoglobulin Therapy
Favorite
13. Evolution of the Infusion Science Specialist
Favorite
14. Stability of Immune Globulin Intravenous, Human-stwk, 10% Liquid Following Pooling and Storage in Flexible Containers
Favorite
15. Immunoglobulin Patient Experience: 2024 IgNS Patient 360 Survey Analysis
Favorite
16. Pediatric Patient Considerations for First Dose of Subcutaneous Immunoglobulin Therapy in the Home
Favorite
17. The Impact of Site of Care on Quality and Safety of IVIG: 2024 IgNS Patient 360 Survey Analysis
Favorite
18. Analysis of Drug Utilization Review (DUR) Alerts and Pharmacist Actions Taken to Improve Accuracy of DUR Evaluations
Favorite
19. Counting the Cost of Vancomycin Premix versus Compounded Formulations In the Home Infusion Setting: A Cost Minimization Analysis
Favorite
2
20. Identifying Safe Patients for Home Initiated Parenteral Nutrition: An App-Based Screening Tool
Favorite
21. Impact of Plasma Collection Date on Antibodies to SARS-CoV-2 in Intravenous Immunoglobulin
Favorite
22. Home Infusion Specialty Drugs: Pharmacist Patient Care Tasks and Time
Favorite
23. Optimizing Subcutaneous Immunoglobulin Therapy: A Modified Delphi Study on Supply Management and Best Practices
Favorite
24. A Somewhat Smelly Case of Antiperspirant Choice and Aluminum Toxicity
Favorite
25. Clinical Guidelines for Home Start Parenteral Nutrition Still Needed for Patient Safety and Prevention of Refeeding Syndrome
Favorite
26. Identification of Food Insecurity and Interdisciplinary Team Interventions in Home Parenteral Nutrition Patients
Favorite
27. Evaluation of Next Generation Automated Compounding Devices to Improve Workflow Efficiency
Favorite
28. THRIVE-1: A Multi-Center, Cross-Sectional, Observational Study To Assess the Prevalence of Choline Deficiency in Patients Dependent on Parenteral Support
Favorite
29. Potential Applications of Ultraviolet Light Disinfection in the Prevention of Central Line Associated Bloodstream Infections in Home Infusion Settings
Favorite
3
30. Can Enteral Feeding Patients, Caregivers and Novices Easily Self-train on a Novel Elastomeric Enteral Feeding System?
Favorite
31. 5-FU Self-Disconnects
Favorite
32. Development and Implementation of a Pharmacist Intervention Tool to Optimize Subcutaneous Immune Globulin Administration for Home Infusion Patients
Favorite
33. Exploring Social Determinants of Health in Primary Immunodeficiency Patients Undergoing Immunoglobulin Replacement Therapy
Favorite